Literature DB >> 3200085

Clofazimine and dapsone compliance in leprosy.

G A Ellard, V K Pannikar, K Jesudasan, M Christian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3200085     DOI： 10.5935/0305-7518.19880026

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  6 in total

1.  Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.

Authors:  S Consigny; A Bentoucha; P Bonnafous; J Grosset; B Ji
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.

Authors:  B Ji; S Sow; E Perani; C Lienhardt; V Diderot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 3.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

4.  Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers.

Authors:  M S Duthie; M N Hay; E M Rada; J Convit; L Ito; L K M Oyafuso; M I P Manini; I M B Goulart; J Lobato; L R Goulart; D Carter; S G Reed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

5.  Leprosy therapy, past and present: can we hope to eliminate it?

Authors:  P V S Prasad; P K Kaviarasan
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

6.  Dapsone reduced cuprizone-induced demyelination via targeting Nrf2 and IKB in C57BL/6 mice.

Authors:  Ahmad Reza Dehpour; Ehsan Khaledi; Tayebeh Noori; Ahmad Mohammadi-Farani; Ladan Delphi; Antoni Sureda; Eduardo Sobarzo-Sanchez; Samira Shirooie
Journal:  Iran J Basic Med Sci       Date:  2022-06       Impact factor: 2.532
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.